Back

SeaStar Medical abstract accepted for ASN Kidney Week 2026 poster presentation

Verifying
  • SeaStar Medical secured a special late-breaker poster slot for SAVE Registry results.
  • October 22, 2026, presentation compares SCD-PED outcomes with a historical cohort.
  • QUELIMMUNE received FDA approval in 2024 for pediatric sepsis-associated AKI.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.